Longboard Pharmaceuticals Operating Income

Longboard Pharmaceuticals (LBPH) currently reports a operating income of $-87M as of September 2024. That compares with $-53M in the prior-year period — down 65.3% year over year. Use the charts on this page to explore Longboard Pharmaceuticals's operating income history and peer comparisons.

Longboard Pharmaceuticals's operating income decreased from $-53M to $-87M — a 65.3% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Longboard Pharmaceuticals reported $-87M in operating income as of September 2024. That compares with $-53M in the prior-year period — down 65.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-87M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Longboard Pharmaceuticals, and consider following LBPH for alerts when major investors trade the stock.

Longboard Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-87M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPH with unrelated industries.